Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy

Abstract In the era of intensity modulation radiation therapy (IMRT), no prospective randomized trial has evaluated the efficacy of adjuvant therapies such as adjuvant concurrent chemoradiotherapy (CCRT), adjuvant sequential chemotherapy and radiotherapy (CT‐RT), and adjuvant CT alone in resectable...

Full description

Saved in:
Bibliographic Details
Main Authors: Mao‐Chih Hsieh, Wei‐Wen Chang, Hsin‐Hsien Yu, Chang‐Yun Lu, Chia‐Lun Chang, Jyh‐Ming Chow, Shee‐Uan Chen, Yunfeng Cheng, Szu‐Yuan Wu
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Cancer Medicine
Subjects:
Adjuvant chemotherapy alone
concurrent chemoradiotherapy
pancreatic adenocarcinoma
sequential chemoradiotherapy
survival
Online Access:https://doi.org/10.1002/cam4.1479
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.1479

Similar Items